InsiderTrades

Form 4 for EYPT EyePoint, Inc.

Accepted 2023-12-06 00:00:00 ET · period of report 2023-12-04 · accession 0001562180-23-008171 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2023-12-06 2023-12-04 EYPT Paggiarino Dario A. Chief Medical Off M - OptEx $10.13 +30.6K 56.3K +119% +$310.2K
DT 2023-12-06 2023-12-04 EYPT Paggiarino Dario A. Chief Medical Off S - Sale+OE $22.00 -30.6K 25.7K -54% -$673.8K
DT 2023-12-06 2023-12-04 EYPT Paggiarino Dario A. Chief Medical Off M - OptEx $0.00 -30.6K 39.4K -44% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-04 M A 30,625 $10.13 56,332 D — —
2 Common Common Stock 2023-12-04 S D 30,625 $22.00 25,707 D — —
3 Derivative Stock Option (Right to Buy) 2023-12-04 M D 30,625 $0.00 39,375 D $10.13 · — to 2032-02-09 30,625 Common Stock (F1) The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years.